← Back to Clinical Trials
Recruiting NCT06189924

Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients

Trial Parameters

Condition Acute Respiratory Failure
Sponsor The Institute of Molecular and Translational Medicine, Czech Republic
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-03-01
Completion 2028-12-31
Interventions
Proteomic analysis of exhaled breath condensate

Brief Summary

Mechanically ventilated intensive care patients will be sampled for a small amount of exhaled breath condensate from the ventilator circuit and for venous blood. Proteomic analysis of the exhaled breath condensate will be performed using mass spectrometry and in the blood sample, corresponding changes in the DNA, RNA, proteins, and metabolites will be studied. Resulting profiles will be correlated with routinely monitored parameters in order to identify patterns corresponding to various pathologies in order to enable their early detection.

Eligibility Criteria

Inclusion Criteria: Intensive care setting Mechanical ventilation Ventilator/ventilator circuit technically suitable for sampling of exhaled breath condensate Exclusion Criteria: Mechanical ventilation challenging to the extent that the insertion of the sampling kit into the ventilator circuit would substantially increase the risk for respiratory deterioration

Related Trials